logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Guohua Zhao

This inventor holds 24 USPTO granted patents and 2 published patent applications and 10 EPO patents, primarily in Integrin Inhibitors. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2002-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Guohua Zhao. Retrieved from https://idiyas.com/inventor/guohua-zhao

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.5

ph-index = 8

Forward Citations = 109(Granted Patents)


Company Filing History:

goldMedal24 out of 3,742 
 
Bristol-Myers Squibb Compnay
 patents

Years Active: 2002-2024

Loading Chart...
Loading Chart...
Areas of Expertise:
Integrin Inhibitors
MGAT2 Inhibitors
Serine Protease Inhibitors
Cyclobutane Compounds
Aryl Dihydropyridinones
Pyrrolone Antagonists
Bicyclic Compounds
Farnesoid X Receptor Modulators
Melanin Concentrating Hormone
Piperidinone Compounds
Tetrahydropyrrolo Compounds
Azetidine Compounds
24 patents (USPTO):Explore Patents
1. 11884661 - 3-substituted propionic acids as αV integrin inhibitors (2024-01-30),
2. 11639353 - Cyclobutanes- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors (2023-05-02),
3. 11292802 - Substituted tetrahydropyrrolo[1,2-a]pyrazines as alpha v integrin inhibitors (2022-04-05),
4. 11014922 - Cyclobutane- and azetidine-containing mono and spirocyclic compounds as αV integrin inhibitors (2021-05-25),
5. 10968219 - 3-substituted propionic acids as αV integrin inhibitors (2021-04-06),
6. 10966967 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2021-04-06),
7. 10730863 - Bridged bicyclic compounds as farnesoid X receptor modulators (2020-08-04),
8. 10717736 - Pyrrole amides as alpha V integrin inhibitors (2020-07-21),
9. 10695328 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2020-06-30),
10. 10369140 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2019-08-06),
11. 9901572 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2018-02-27),
12. 9856244 - Dihydropyridinone MGAT2 inhibitors (2018-01-02),
13. 9701672 - Dihydropyridinone MGAT2 inhibitors for use in the treatment of metabolic disorders (2017-07-11),
14. 9663466 - Aryl dihydropyridinones and piperidinone MGAT2 inhibitors (2017-05-30),
15. 9586900 - Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists (2017-03-07),

Title: The Innovative Journey of Guohua Zhao

Introduction: Guohua Zhao, a distinguished inventor based in Princeton, NJ, has made significant contributions to the field of technology through his groundbreaking innovations.

Latest Patents: Guohua Zhao holds several patents in the areas of artificial intelligence, renewable energy, and biotechnology, showcasing his diverse range of expertise and creativity.

Career Highlights: With a career spanning over two decades, Guohua Zhao has worked with leading research institutions and tech companies, consistently pushing the boundaries of what is possible in the world of inventions.

Collaborations: Throughout his career, Guohua Zhao has collaborated with top scientists, engineers, and researchers globally, fostering a culture of innovation and knowledge-sharing in the industry.

Conclusion: Guohua Zhao's passion for innovation and his relentless pursuit of excellence continue to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…